136 related articles for article (PubMed ID: 37723625)
1. Nonclinical safety assessment of an mRNA Covid-19 vaccine candidate following repeated administrations and biodistribution.
Broudic K; Laurent S; Perkov V; Simon C; Garinot M; Truchot N; Latour J; Désert P
J Appl Toxicol; 2024 Mar; 44(3):371-390. PubMed ID: 37723625
[TBL] [Abstract][Full Text] [Related]
2. A self-amplifying mRNA SARS-CoV-2 vaccine candidate induces safe and robust protective immunity in preclinical models.
Maruggi G; Mallett CP; Westerbeck JW; Chen T; Lofano G; Friedrich K; Qu L; Sun JT; McAuliffe J; Kanitkar A; Arrildt KT; Wang KF; McBee I; McCoy D; Terry R; Rowles A; Abrahim MA; Ringenberg MA; Gains MJ; Spickler C; Xie X; Zou J; Shi PY; Dutt T; Henao-Tamayo M; Ragan I; Bowen RA; Johnson R; Nuti S; Luisi K; Ulmer JB; Steff AM; Jalah R; Bertholet S; Stokes AH; Yu D
Mol Ther; 2022 May; 30(5):1897-1912. PubMed ID: 34990810
[TBL] [Abstract][Full Text] [Related]
3. Design of SARS-CoV-2 hFc-Conjugated Receptor-Binding Domain mRNA Vaccine Delivered
Elia U; Ramishetti S; Rosenfeld R; Dammes N; Bar-Haim E; Naidu GS; Makdasi E; Yahalom-Ronen Y; Tamir H; Paran N; Cohen O; Peer D
ACS Nano; 2021 Jun; 15(6):9627-9637. PubMed ID: 33480671
[TBL] [Abstract][Full Text] [Related]
4. rVSV-ΔG-SARS-CoV-2-S vaccine: repeated intramuscular (IM) toxicity, local tolerance, immunogenicity and biodistribution study in NZW rabbits.
Rosner A; Steiner M; Melamed S; Politi B; Vitner E; Tamir H; Achdout H; Cherry L; Avraham R; Yahalom-Ronen Y; Levy H; Beth-Din A; Stein D; Mechaly A; Fisher M; Fatelevich E; Weiss S; Kronfeld N; Madar-Shapiro L; Nyska A; Yitzhaki S; Paran N; Israely T; Marcus H; Madar-Balakirski N
Arch Toxicol; 2022 Aug; 96(8):2329-2339. PubMed ID: 35577986
[TBL] [Abstract][Full Text] [Related]
5. Nonclinical safety evaluation of a novel ionizable lipid for mRNA delivery.
Broudic K; Amberg A; Schaefer M; Spirkl HP; Bernard MC; Desert P
Toxicol Appl Pharmacol; 2022 Sep; 451():116143. PubMed ID: 35843341
[TBL] [Abstract][Full Text] [Related]
6. Novel Ionizable Lipid Nanoparticles for SARS-CoV-2 Omicron mRNA Delivery.
Long J; Yu C; Zhang H; Cao Y; Sang Y; Lu H; Zhang Z; Wang X; Wang H; Song G; Yang J; Wang S
Adv Healthc Mater; 2023 May; 12(13):e2202590. PubMed ID: 36716702
[TBL] [Abstract][Full Text] [Related]
7. Characterization of stability, safety and immunogenicity of the mRNA lipid nanoparticle vaccine Iribovax® against COVID-19 in nonhuman primates.
Zamani P; Mashreghi M; Rezazade Bazaz M; Zargari S; Alizadeh F; Dorrigiv M; Abdoli A; Aminianfar H; Hatamipour M; Zarqi J; Behboodifar S; Samsami Y; Khorshid Sokhangouy S; Sefidbakht Y; Uskoković V; Rezayat SM; Jaafari MR; Mozaffari-Jovin S
J Control Release; 2023 Aug; 360():316-334. PubMed ID: 37355212
[TBL] [Abstract][Full Text] [Related]
8. Safety and Efficacy of Combined Intramuscular/Intranasal RAZI-COV PARS Vaccine Candidate Against SARS-CoV-2: A Preclinical Study in Several Animal Models.
Banihashemi SR; Es-Haghi A; Fallah Mehrabadi MH; Nofeli M; Mokarram AR; Ranjbar A; Salman M; Hajimoradi M; Razaz SH; Taghdiri M; Bagheri M; Dadar M; Hassan ZM; Eslampanah M; Salehi Najafabadi Z; Lotfi M; Khorasani A; Rahmani F
Front Immunol; 2022; 13():836745. PubMed ID: 35693788
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine.
Baden LR; El Sahly HM; Essink B; Kotloff K; Frey S; Novak R; Diemert D; Spector SA; Rouphael N; Creech CB; McGettigan J; Khetan S; Segall N; Solis J; Brosz A; Fierro C; Schwartz H; Neuzil K; Corey L; Gilbert P; Janes H; Follmann D; Marovich M; Mascola J; Polakowski L; Ledgerwood J; Graham BS; Bennett H; Pajon R; Knightly C; Leav B; Deng W; Zhou H; Han S; Ivarsson M; Miller J; Zaks T;
N Engl J Med; 2021 Feb; 384(5):403-416. PubMed ID: 33378609
[TBL] [Abstract][Full Text] [Related]
10. Lipid Nanoparticle RBD-hFc mRNA Vaccine Protects hACE2 Transgenic Mice against a Lethal SARS-CoV-2 Infection.
Elia U; Rotem S; Bar-Haim E; Ramishetti S; Naidu GS; Gur D; Aftalion M; Israeli M; Bercovich-Kinori A; Alcalay R; Makdasi E; Chitlaru T; Rosenfeld R; Israely T; Melamed S; Abutbul Ionita I; Danino D; Peer D; Cohen O
Nano Lett; 2021 Jun; 21(11):4774-4779. PubMed ID: 34032435
[TBL] [Abstract][Full Text] [Related]
11. Toxicity and Local Tolerance of a Novel Spike Protein RBD Vaccine Against SARS-CoV-2, Produced Using the C1
Ramot Y; Kronfeld N; Ophir Y; Ezov N; Friedman S; Saloheimo M; Vitikainen M; Ben-Artzi H; Avigdor A; Tchelet R; Valbuena Crespo N; Emalfarb M; Nyska A
Toxicol Pathol; 2022 Apr; 50(3):294-307. PubMed ID: 35514116
[TBL] [Abstract][Full Text] [Related]
12. The evaluation of novel oral vaccines based on self-amplifying RNA lipid nanparticles (saRNA LNPs), saRNA transfected Lactobacillus plantarum LNPs, and saRNA transfected Lactobacillus plantarum to neutralize SARS-CoV-2 variants alpha and delta.
Keikha R; Hashemi-Shahri SM; Jebali A
Sci Rep; 2021 Oct; 11(1):21308. PubMed ID: 34716391
[TBL] [Abstract][Full Text] [Related]
13. SMART-lipid nanoparticles enabled mRNA vaccine elicits cross-reactive humoral responses against the omicron sub-variants.
Mahalingam G; Rachamalla HK; Arjunan P; Karuppusamy KV; Periyasami Y; Mohan A; Subramaniyam K; M S; Rajendran V; Moorthy M; Varghese GM; Mohankumar KM; Thangavel S; Srivastava A; Marepally S
Mol Ther; 2024 May; 32(5):1284-1297. PubMed ID: 38414245
[TBL] [Abstract][Full Text] [Related]
14. Safety, immunogenicity and efficacy of Relcovax®, a dual receptor binding domain (RBD) and nucleocapsid (N) subunit protein vaccine candidate against SARS-CoV-2 virus.
Sathe N; Shaikh S; Bhavsar M; Parte L; Gadiparthi A; Kad S; Sensarma S; Nalband H; Sangapillai R; Sivashanmuganathan S; Pusalkar R; Anandan S; Masand G; Pratapreddy K; Harinarayana Rao S; Gokhale A; Vidyadhar Reddy GEC; Karanam G; Phatarphekar A; Rao P; Ramana V; Ramnath RL
Vaccine; 2024 Feb; 42(5):1051-1064. PubMed ID: 37816655
[TBL] [Abstract][Full Text] [Related]
15. Safety and immunogenicity of the SARS-CoV-2 ARCoV mRNA vaccine in Chinese adults: a randomised, double-blind, placebo-controlled, phase 1 trial.
Chen GL; Li XF; Dai XH; Li N; Cheng ML; Huang Z; Shen J; Ge YH; Shen ZW; Deng YQ; Yang SY; Zhao H; Zhang NN; Zhang YF; Wei L; Wu KQ; Zhu MF; Peng CG; Jiang Q; Cao SC; Li YH; Zhao DH; Wu XH; Ni L; Shen HH; Dong C; Ying B; Sheng GP; Qin CF; Gao HN; Li LJ
Lancet Microbe; 2022 Mar; 3(3):e193-e202. PubMed ID: 35098177
[TBL] [Abstract][Full Text] [Related]
16. STING Agonist-Derived LNP-mRNA Vaccine Enhances Protective Immunity Against SARS-CoV-2.
Zhang Y; Yan J; Hou X; Wang C; Kang DD; Xue Y; Du S; Deng B; McComb DW; Liu SL; Zhong Y; Dong Y
Nano Lett; 2023 Apr; 23(7):2593-2600. PubMed ID: 36942873
[TBL] [Abstract][Full Text] [Related]
17. Artificial Cell Membrane Polymersome-Based Intranasal Beta Spike Formulation as a Second Generation Covid-19 Vaccine.
Lam JH; Shivhare D; Chia TW; Chew SL; Sinsinbar G; Aw TY; Wong S; Venkataraman S; Lim FWI; Vandepapeliere P; Nallani M
ACS Nano; 2022 Oct; 16(10):16757-16775. PubMed ID: 36223228
[TBL] [Abstract][Full Text] [Related]
18. Trivalent mRNA Vaccine against SARS-CoV-2 and Variants with Effective Immunization.
Wang J; Zhang Y; Liu C; Zha W; Dong S; Wang Y; Jiang Y; Xing H; Li X
Mol Pharm; 2023 Oct; 20(10):4971-4983. PubMed ID: 37699256
[TBL] [Abstract][Full Text] [Related]
19. Delivery and Expression of mRNA in the Secondary Lymphoid Organs Drive Immune Responses to Lipid Nanoparticle-mRNA Vaccines after Intramuscular Injection.
Takanashi A; Pouton CW; Al-Wassiti H
Mol Pharm; 2023 Aug; 20(8):3876-3885. PubMed ID: 37491979
[TBL] [Abstract][Full Text] [Related]
20. A Single Immunization with Nucleoside-Modified mRNA Vaccines Elicits Strong Cellular and Humoral Immune Responses against SARS-CoV-2 in Mice.
Laczkó D; Hogan MJ; Toulmin SA; Hicks P; Lederer K; Gaudette BT; Castaño D; Amanat F; Muramatsu H; Oguin TH; Ojha A; Zhang L; Mu Z; Parks R; Manzoni TB; Roper B; Strohmeier S; Tombácz I; Arwood L; Nachbagauer R; Karikó K; Greenhouse J; Pessaint L; Porto M; Putman-Taylor T; Strasbaugh A; Campbell TA; Lin PJC; Tam YK; Sempowski GD; Farzan M; Choe H; Saunders KO; Haynes BF; Andersen H; Eisenlohr LC; Weissman D; Krammer F; Bates P; Allman D; Locci M; Pardi N
Immunity; 2020 Oct; 53(4):724-732.e7. PubMed ID: 32783919
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
